A comparison of aspiration, antazoline sclerotherapy and surgery in the treatment of hydrocele.
Of 98 hydroceles (mean volume 125 ml) in a consecutive series of 92 patients, treated initially by aspiration, 14% (mean volume 70 ml) were cured. The 76 recurring hydroceles (mean volume 146 ml) were then randomised to either antazoline sclerotherapy on an out-patient basis or surgery. Cure rates were 89 and 100%, respectively, at follow-up 6 months later. Operated patients were admitted for a mean duration of 2.5 days. The results indicated that aspiration alone was inadequate, and sclerotherapy is advocated as the first choice of treatment for hydrocele.
Department of Surgery, Frederikssund Sygehus, Denmark.
J U
JU
Roosen
T
T
Larsen
E
E
Iversen
J B
JB
Berg
D000328:Adult; D000368:Aged; D000865:Antazoline / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use; D015911:Sclerotherapy; D013396:Suction; D006848:Testicular Hydrocele / Q000601:surgery* / Q000628:therapy*
D012597:Sclerosing Solutions; D000865:Antazoline